Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Financial Results:
Indoco Remedies Ltd reported Revenues for Q4FY24 of ₹450.00 Crores up from ₹428.00 Crore year on year, a rise of 5.14%.
Total Expenses for Q4FY24 of ₹439.00 Crores up from ₹390.00 Crores year on year, a rise of 12.56%.
Consolidated Net Profit of ₹22.00 Crores down 15.38% from ₹26.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.46, down 12.14% from ₹2.80 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.